Nuvectis Pharma, Inc. — Investor Relations & Filings
Filings indexed
248
across all filing types
Latest filing
2026-05-05
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
NVCT
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines and novel targeted therapeutics for the treatment of cancer. The company aims to address serious conditions with unmet medical needs within oncology. Its development pipeline includes the product candidate NXP800.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Nuvectis Pharma, Inc. (0001875558) (Filer) | 2026-05-05 | English | |
| 8-K - Nuvectis Pharma, Inc. (0001875558) (Filer) | 2026-05-05 | English | |
| EFFECT - Nuvectis Pharma, Inc. (0001875558) (Filer) | 2026-02-23 | English | |
| S-3 Filing | 2026-02-13 | English | |
| 10-K Filing | 2026-02-11 | English | |
| 8-K Filing | 2026-02-11 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 41382937 | 10-Q - Nuvectis Pharma, Inc. (0001875558) (Filer) | 2026-05-05 | English | ||
| 41357220 | 8-K - Nuvectis Pharma, Inc. (0001875558) (Filer) | 2026-05-05 | English | ||
| 32826255 | EFFECT - Nuvectis Pharma, Inc. (0001875558) (Filer) | 2026-02-23 | English | ||
| 32150856 | S-3 Filing | 2026-02-13 | English | ||
| 32151018 | 10-K Filing | 2026-02-11 | English | ||
| 32150824 | 8-K Filing | 2026-02-11 | English | ||
| 13504478 | OWNERSHIP DOCUMENT | 2026-01-09 | English | ||
| 13504481 | OWNERSHIP DOCUMENT | 2026-01-09 | English | ||
| 13504482 | OWNERSHIP DOCUMENT | 2026-01-09 | English | ||
| 13504483 | OWNERSHIP DOCUMENT | 2026-01-09 | English | ||
|
2025
5 filings
| |||||
| 13504484 | OWNERSHIP DOCUMENT | 2025-11-06 | English | ||
| 13504485 | OWNERSHIP DOCUMENT | 2025-11-06 | English | ||
| 13504486 | OWNERSHIP DOCUMENT | 2025-11-06 | English | ||
| 13504487 | FORM 8-K | 2025-11-04 | English | ||
| 13504488 | 10-Q | 2025-11-04 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectar Biosciences, Inc.
Clinical-stage biopharma developing targeted cancer treatme…
|
CLRB | US | Manufacturing |
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
Nuvectis Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33912/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33912 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33912 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33912 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33912}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Nuvectis Pharma, Inc. (id: 33912)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.